PE Raids Roche

Premium

PE’s recent raid of the upper ranks of Roche’s diagnostics division was likely a sign of what’s to come.

Last month PE reeled in three Roche execs who will ramp up the company’s molecular diagnostics division. Kathy Ordonez, who oversaw Roche Molecular’s rise to dominance in the PCR arena over the last nine years, is bringing two colleagues with her to PE: Tom White, Roche Molecular’s vice president of R&D, and John Sinensky, its vice president of genetics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.